BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2007
View Archived Issues
Novel therapies targeting the prolactin receptor block tumor recurrence in breast cancer models
Read More
GEM OS1 Bone Graft begins pivotal study in E.U.
Read More
ARCA's Series B financing to support regulatory filing of bucindolol
Read More
Melanoma-specific CD8+ T-cell responses seen with melanoma pharmaccine
Read More
Snapshots on cancer immunotherapy
Read More
HDAC inhibitors promote memory consolidation via activation of CREB-mediated gene transcription
Read More
Snapshots of preclinical studies in hematology
Read More
Proellex shows superior efficacy and safety in endometriosis compared to Lucrin
Read More
Enrollment completed in phase II trial of Huperzine A
Read More
Enrollment open in U.K. study of Reolysin with gemcitabine in advanced cancers
Read More
New phase I study for terameprocol in solid tumors
Read More
OT-551 studied in phase II trial for geographic atrophy
Read More
NRC-IRAP contribution to support development of WBI-2100
Read More
Coley acquires 3M's therapeutic Toll-like receptor R&D programs
Read More
Recent patents describe new treatment options for endocrine disorders
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
New therapeutic options for cancer imparted in recent patents
Read More
Gabapentin GR begins phase II trial for menopausal hot flashes
Read More
Valopicitabine triple combination therapy shows good HCV RNA clearance rates
Read More
U.S. orphan drug designation for Multikine
Read More
Immtech grants U.S. commercialization rights to Par for pafuramidine
Read More
Pfizer's anti-IGF-IR antibody shows clinical benefit as a single agent
Read More
Phase II data on picoplatin disclosed
Read More
Pazopanib shows activity in mRCC and ovarian cancer
Read More
Astion obtains extra capital to accelerate phase III for ASF-1096
Read More
Favrille acquires anti-CD20 monoclonal antibodies from Diversa
Read More
SPA agreement for phase III trial of Xanafide in secondary AML
Read More
Elestrin launched in U.S.
Read More
FDA Advisory Committee recommends against approval of rimonabant
Read More